Which of the following is a non-pharmacologic component of smoking cessation strategy?

Which of the following is a non-pharmacologic component of smoking cessation strategy?

• A. Behavioral therapy/support groups
• B. Nicotine replacement therapy
• C. Bupropion
• D. Varenicline

Answer: (A)

Quitting smoking is supported by both pharmacologic and nonpharmacologic approaches, with the nonpharmacologic component focusing on behavior change and psychosocial support. Behavioral therapy and support groups provide strategies to cope with cravings, identify and manage triggers, plan for quit dates, and create a supportive environment. They don’t involve medications, which is what makes them nonpharmacologic. In contrast, nicotine replacement therapy delivers nicotine to ease withdrawal, while bupropion and varenicline are prescription medicines that act on brain pathways to reduce cravings and withdrawal symptoms. So the option that represents a nonpharmacologic component is the behavioral therapy and support groups, which complement pharmacologic aids when used together.

Quitting smoking is supported by both pharmacologic and nonpharmacologic approaches, with the nonpharmacologic component focusing on behavior change and psychosocial support. Behavioral therapy and support groups provide strategies to cope with cravings, identify and manage triggers, plan for quit dates, and create a supportive environment. They don’t involve medications, which is what makes them nonpharmacologic. In contrast, nicotine replacement therapy delivers nicotine to ease withdrawal, while bupropion and varenicline are prescription medicines that act on brain pathways to reduce cravings and withdrawal symptoms. So the option that represents a nonpharmacologic component is the behavioral therapy and support groups, which complement pharmacologic aids when used together.